FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines
Posted on: September 1, 2022 - 8:31am
On August 31st, the FDA authorized emergency use of the Moderna and Pfizer-BioNTech bivalent COVID-19 boosters as a single dose at least two months following primary or booster vaccination. The updated boosters provide protection against the original strain of COVID-19 and the omicron variant.
Eligibility:
- Individuals 18 years and older are eligible for a single booster dose of the Moderna bivalent COVID-19 vaccine
- Individuals 12 years and older are eligible for a single booster dose of the Pfizer-BioNTech bivalent COVID-19 vaccine
For any questions regarding the bivalent COVID-19 vaccines and anticipated COVID-19 vaccination clinics, please contact the Waltham Health Department at 781-314-3305.